NSE/COROMANDEL

COROMANDELCoromandel International Ltd

Chemicals · NSE

₹2,050.2-1.33%

52-wk low52-WEEK RANGE52-wk high

₹1,846.5+11.0% from low ·-23.8% from high₹2,691.4

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

COROMANDEL+2.27% · 1Y

Range high ₹2,718.9Range low ₹1,818.1Latest ₹2,050.2252 bars · daily-close · NSE bhavcopy + 10Y history

ChemicalsAgricultural InputsMurugappa GroupLargecapLow Risk

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite50/100

Performance

Low

Hasn't fared well — amongst the weak performers.

· 52w return -6.7% — underperformer
· Below 200-DMA (-8.7%) — downtrend

Valuation

Low

Appears to be fairly valued to cheap vs peers.

· P/E 25.3 vs sector median 38.2 — 34% cheaper

Growth

Medium

Steady but not standout growth.

· Revenue YoY +9.2%
· Profit YoY +25.8% — strong earnings growth

Profitability

Medium

Average profitability vs peers.

· ROE 19.6%
· Top quartile ROE in Chemicals

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeB(64/100)

Durability

A+

85/100

Financially resilient — strong quality + solvency profile.

Show 4 drivers

Piotroski F-score6/9 (67pt)
Altman Z" score5.27 (100pt)
Debt/Equity0.12 (100pt)
ROE19.6% (79pt)

Valuation

64/100

Fairly priced — not a bargain, not stretched.

Show 4 drivers

P/E vs sector (25.3 / 38.2)66% (100pt)
P/B4.97 (40pt)
Dividend yield0.73% (18pt)
EV/EBITDA18.9 (40pt)

Momentum

42/100

Momentum is muted; trend is unclear or rolling over.

Show 5 drivers

52w change-6.7% (37pt)
DMA-trend alignmentdown (25pt)
RSI (14)49.4 (60pt)
Price vs 200-DMA-9.2% (42pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)25.31

UNDERVALUED

CheapestP/E 25.3 at 15th %ile of sector — cheaper than 85% of peers.Most expensive

P/B4.97

FAIR

CheapestP/B 4.97 at 62th %ile of sector.Most expensive

EV/EBITDA18.94

OVERVALUED

Monthly seasonality

Avg monthly return over 10 years · historical — not a forecast

Best: Jun +6.11% · Worst: Feb -1.66%

Jan

+1.2%

60% win

Feb

-1.7%

40% win

Mar

-0.4%

40% win

Apr

+4.5%

70% win

May

+5.2%

90% win

Jun

+6.1%

Monthly return distribution

Distribution of 120 monthly returns

Mean

+2.18%

Median

+1.77%

Std dev

8.10%

Best

+22.5%

Worst

-16.1%

% positive

58%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 3

Lean balance sheet (D/E 0.12)
Low leverage means earnings are less sensitive to rate cycles
Bankruptcy risk low (Altman Z″ 5.27)
Z″ above 2.60 sits squarely in the 'safe' zone
Top quartile ROE in Chemicals
Rank 2 of 13 peers

WEAKNESSES · 0

No material weaknesses flag from the numbers

OPPORTUNITIES · 1

25% upside to consensus target (₹2569)
10 analysts see fair value materially higher

THREATS · 0

No immediate threats from the data

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

-1.3%

-4.9%

+2.4%

-9.7%

-8.9%

-0.6%

+32.5%

+20.9%

10Y

+25.0%

Fundamentals

VALUATION

Market cap

₹60,568 Cr

P/E (TTM)

25.3

P/E (fwd)

22.1

next 12m

P/B

4.97

EV/EBITDA

18.9

Book value

₹413.45

per share

PROFITABILITY · QUALITY

ROE

19.6%

ROCE

—

Net margin

8.6%

Op margin

7.4%

Gross margin

24.6%

D/E

0.12

GROWTH · MARKET

Rev YoY

+9.2%

Profit YoY

+25.8%

Div yield

0.73%

Payout

14.8%

52w change

-6.7%

Beta

0.23

defensive

Pros and cons

Auto-derived from ratios · not a buy/sell recommendation

PROS · 5

+Trading at -33.7% vs sector median P/EP/E 25.3 vs Chemicals median 38.2 — relative value on earnings
+Forward P/E materially below trailing (22.1x vs 25.3x)Street expects earnings growth that compresses the multiple — positive surprise cushion
+Profit growing fast (+25.8% YoY)Operating leverage kicking in — bottom line out-growing top line
+Nearly debt-free (D/E 0.12)Low financial risk — funds growth from internal accruals, resilient in downturns
++25% upside to analyst consensus target10 analysts average target of ₹2569 vs current ₹2055

CONS · 0

No material concerns surface from the ratios alone — still layer qualitative research.

Sector-relative context

Chemicals · 13 peers

P/E (TTM)

This stock

25.31

Sector median

38.18

Rank 2/13 (92th %ile)

ROE

This stock

19.6%

Sector median

13.4%

Rank 12/13 (15th %ile)

P/B

This stock

4.97

Sector median

4.34

Rank 8/13 (46th %ile)

Quality score · Piotroski F-score

6 / 9

Decent quality — clears Piotroski bar

✓Profitable (positive net income)· Most basic check — company makes money
✓Positive return on assets· Assets generate returns
✓Positive operating cash flow· Profits are backed by real cash, not accruals
✓Operating CF exceeds net profit· Healthy cash conversion — no aggressive revenue recognition
✗Long-term debt decreased YoY· Deleveraging — lower refinancing risk
✗ROA improved YoY· Getting more productive with the asset base
✗Operating margin expanded YoY· Pricing power or cost discipline
✓

Forensic score · Altman Z″ (emerging markets)

Bankruptcy-risk predictor · 1995 Altman emerging-market revision

SAFE5.27

Z″ = 5.27 — well inside the SAFE zone. Low bankruptcy risk signal across liquidity, profitability and solvency inputs.

Component	Ratio	Weight	Contribution
Working Capital / Total Assets (A)	0.378	×6.56	2.478
Retained Earnings / Total Assets (B)	0.321	×3.26	1.047
EBIT / Total Assets (C)	0.185	×6.72	1.241
Book Equity / Total Liabilities (D)	0.479	×1.05	0.502

Zones: Z″ ≥ 2.60 safe · 1.10–2.60 grey · < 1.10 distress. All four inputs derived from latest annual filing.

Analyst consensus

10 analysts · BUY

Target mean

₹2569.00

Target high

₹3291.00

Target low

₹2260.00

Upside vs today

+25.0%

Street consensus target is +25.0% vs current price. Consensus is a lagging sentiment read, not a forecast.

Company + balance sheet snapshot

Industry

Agricultural Inputs

Employees

5,540

Shares out

29.5

Revenue (TTM)

₹30,464 Cr

EBITDA

₹3,069 Cr

Total debt

₹1,471 Cr

Cash

₹4,263 Cr

Net debt

₹-2,792 Cr

Quarterly results

Last 5 quarters · ₹ Cr (Screener.in-grade depth)

Metric	2024-Q3	2024-Q4	2025-Q1	2025-Q2	2025-Q4
Revenue	7,433	6,935	-3,160	7,042	8,779
Operating profit	906	651	431	662	653
OPM %	12.2%	9.4%	-13.6%	9.4%	7.4%
Interest	66	73

Annual P&L

Last 4 years · ₹ Cr · all line items

Metric	2022-FY	2023-FY	2024-FY	2025-FY
Revenue	12,293	15,099	13,832	15,937
Operating profit	2,083	2,911	2,239	2,429
OPM %	16.9%	19.3%	16.2%	15.2%
Interest	68	179	176	252

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
COROMANDELTHIS Coromandel International Limited	₹2,050.2	-6.7%	60,568	25.3	4.97	19.6%	0.12	+9.2%
PIDILITIND Pidilite Industries Limited	₹1,393.4	-53.9%	1,41,522	62.0	14.82	23.9%	0.04	+10.1%
SRF SRF Limited	₹2,494.5	-17.7%	73,067	41.0	5.51	13.4%	0.35	+6.3%
PIIND PI Industries Limited	₹3,139.7	-14.8%	47,028	32.4	4.34	—	0.02	+4.1%
NAVINFLUOR Navin Fluorine International Limited	₹6,284	+49.1%	32,747	59.0	9.05	—	0.33	+13.8%
DEEPAKNTR Deepak Nitrite Limited	₹1,538.1	-23.8%	20,767	39.0	3.76	9.7%	0.22	+204.0%
ATUL Atul Limited	₹6,600	+10.5%	19,356	32.6	3.27	10.1%	0.03	+18.1%
AARTIIND Aarti Industries Limited	₹440.85	+4.6%	16,067	42.6	2.82	6.6%	0.70	+14.1%
FINEORG Fine Organic Industries Limited	₹4,907.5	+13.9%	14,852	37.4	6.00	16.0%	0.01	+13.0%

ASK AXEL

Dig deeper into COROMANDEL

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for COROMANDEL — all in one sourced reply.

Ask free in chat

Run these tools on COROMANDEL

Historical return →

"If I had bought COROMANDEL in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on COROMANDEL

Brokerage + charges →

All-in cost for trading COROMANDEL

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

Quarter	EPS estimate	EPS actual	Surprise %
-1q	17.27	17.14	-0.7%
-2q	25.17	27.30	+8.5%
-3q	13.93	17.12	+22.9%
-4q	9.33	19.67	+110.8%

Date	Amount
2026-02-04	₹9.00
2025-07-17	₹9.00
2025-02-05	₹6.00
2024-07-26	₹6.00
2023-07-14	₹6.00
2023-02-17	₹6.00
2022-07-14	₹6.00
2022-02-14	₹6.00
2021-07-15	₹6.00
2021-02-10	₹6.00
2020-07-16	₹12.00
2019-07-10	₹3.50
2019-01-31	₹3.00
2018-07-19	₹3.50
2018-03-22	₹3.00
2017-07-13	₹5.00
2016-07-14	₹4.00

Metric	2022-FY	2023-FY	2024-FY	2025-FY
Equity capital	29	29	29	29
Reserves	3,623	5,279	6,799	8,444
Borrowings	395	393	492	780
Other liabilities	8	8	7	6
Total liabilities	11,285	14,235	15,852	18,928
Fixed assets	2,227	2,652	3,014	4,322
CWIP	143	461	225	497
Investments	210	139	109	170
Other assets	4	4	4	14
Total assets	11,285	14,235	15,852	18,928

Metric	2022-FY	2023-FY	2024-FY	2025-FY
CF Operating	2,078	591	1,428	2,464
CF Investing	-1,622	639	-1,338	-2,638
CF Financing	-443	-543	-363	-698
Net cash flow	14	688	-273	-872
Free cash flow	1,800	-14	901	1,613

Metric	2025-FY	2024-FY	2023-FY	2022-FY
OPM %	15.2%	16.2%	19.3%	16.9%
Net margin %	13.0%	11.9%	13.3%	12.4%
ROE %	27.0%	27.1%	44.9%	41.8%
ROCE %	36.0%	36.3%	59.1%	52.3%
Debt / Equity	0.09	0.07	0.07	0.11
Interest coverage	11.8×	13.4×	16.1×	31.2×
Revenue growth YoY	+15.2%	-8.4%	+22.8%	—
Profit growth YoY	+25.8%	-18.4%	+31.7%	—

COROMANDELCoromandel International Ltd

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Pros and cons

Sector-relative context

Quality score · Piotroski F-score

Forensic score · Altman Z″ (emerging markets)

Analyst consensus

Company + balance sheet snapshot

Quarterly results

Annual P&L

Peer comparison · Chemicals

Ask Axel about COROMANDEL

Recent news

Dig deeper into COROMANDEL

Run these tools on COROMANDEL

Technical snapshot

Earnings history + surprises

Dividends + splits history

Recent news

Stock scorecard

SWOT analysis

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

Fundamentals

Pros and cons

Sector-relative context

Quality score · Piotroski F-score

Forensic score · Altman Z″ (emerging markets)

Analyst consensus

Company + balance sheet snapshot

Quarterly results

Annual P&L

Balance sheet

Cash flow statement

Ratios

Peer comparison · Chemicals